ioGenetics

Executive Summary

ioGenetics is a San Diego-based private biotechnology company specializing in genetics and genomics, with a focus on protein products and diagnostic solutions. Founded in 2015, the company aims to advance precision medicine through innovative molecular tools. While specific financials and pipeline details are not publicly disclosed, ioGenetics actively seeks collaborations to progress its technologies toward commercialization. The company operates in the competitive diagnostics and genomics space, targeting unmet needs in disease detection and monitoring. Given its early-stage profile and limited public information, the company's trajectory remains uncertain, but its strategic partnerships and product development efforts could be key value drivers.

Upcoming Catalysts (preview)

• Q3 2026Strategic Partnership with Major Pharma40% success
• Q2 2026Series A Funding Round Announcement50% success
• Q4 2026Launch of Novel Diagnostic Test30% success